MedPath

L-arginine

Generic Name
L-arginine
Brand Names
Clinimix 2.75/5
Drug Type
Small Molecule
CAS Number
74-79-3

L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)

Phase 3
Completed
Conditions
Smear Positive Pulmonary Tuberculosis
Interventions
First Posted Date
2008-05-14
Last Posted Date
2012-01-18
Lead Sponsor
Menzies School of Health Research
Target Recruit Count
200
Registration Number
NCT00677339
Locations
🇮🇩

Timika Tuberculosis Clinic and Community Hospital, Timika, Papua Province, Indonesia

Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria

Phase 2
Suspended
Conditions
Severe Falciparum Malaria
Interventions
Other: Normal saline
First Posted Date
2008-02-15
Last Posted Date
2024-03-13
Lead Sponsor
Menzies School of Health Research
Target Recruit Count
8
Registration Number
NCT00616304
Locations
🇮🇩

Mitra Masyarakat Hospital, Timika, Papua, Indonesia

Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Interventions
First Posted Date
2008-01-29
Last Posted Date
2018-09-12
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
54
Registration Number
NCT00603720
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy

Phase 3
Completed
Conditions
Hypertension in Pregnancy
Interventions
Drug: Placebo
First Posted Date
2007-12-12
Last Posted Date
2009-09-10
Lead Sponsor
University of Modena and Reggio Emilia
Target Recruit Count
80
Registration Number
NCT00571766
Locations
🇮🇹

University of Modena and Reggio Emilia, Modena, Emilia Romagna, Italy

Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.

Phase 3
Completed
Conditions
Cardiovascular Disease
First Posted Date
2006-12-07
Last Posted Date
2006-12-12
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
150
Registration Number
NCT00408577
Locations
🇮🇹

Scientific Institute San Raffaele, Milan, Italy

The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis

Phase 2
Completed
Conditions
Cystic Fibrosis
Interventions
First Posted Date
2006-11-30
Last Posted Date
2013-09-02
Lead Sponsor
The Hospital for Sick Children
Target Recruit Count
20
Registration Number
NCT00405665
Locations
🇨🇦

The Hospital for Sick Children, Toronto, Ontario, Canada

🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

L-Arginine in the Treatment of Peripheral Arterial Disease

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Peripheral Vascular Diseases
First Posted Date
2006-01-31
Last Posted Date
2014-03-05
Lead Sponsor
Stanford University
Registration Number
NCT00284076

Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2006-01-23
Last Posted Date
2017-05-30
Lead Sponsor
University of California, Davis
Target Recruit Count
20
Registration Number
NCT00280683
Locations
🇺🇸

University of California, Davis General Clinical Research Center, Sacramento, California, United States

Glomerular Injury of Preeclampsia

Not Applicable
Completed
Conditions
Pre-Eclampsia
First Posted Date
2006-01-11
Last Posted Date
2010-01-14
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
45
Registration Number
NCT00275158
Locations
🇺🇸

Stanford University Medical Center, Stanford, California, United States

L-Arginine in Pre-Eclampsia

Phase 3
Completed
Conditions
Pre-Eclampsia
First Posted Date
2005-09-12
Last Posted Date
2006-12-22
Lead Sponsor
Mario Negri Institute for Pharmacological Research
Target Recruit Count
30
Registration Number
NCT00157521
Locations
🇮🇹

Obstetrics and Ginecology Division, Brescia, Italy

🇮🇹

Hospital "Ospedali Riuniti", Unit of Obstetrics and Ginecology, Bergamo, Italy

© Copyright 2025. All Rights Reserved by MedPath